Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$504K Sell
99,183
-50,316
-34% -$232K 0.01% 554
2026
Q1
$655K Sell
149,499
-22,811
-13% -$101K 0.02% 478
2025
Q4
$748K Sell
172,310
-27,000
-14% -$100K 0.02% 423
2025
Q3
$665K Hold
199,310
0.02% 361
2025
Q2
$704K Buy
199,310
+70,827
+55% +$207K 0.02% 358
2025
Q1
$348K Hold
128,483
0.01% 418
2024
Q4
$391K Buy
+128,483
New +$422K 0.01% 381

Other funds holding PYPD

J. Goldman & Co's PYPD Position: Q2 2026 in Review

J. Goldman & Co reduced its PolyPid (PYPD) stake by 34% in Q2 2026, selling an estimated $232K and leaving 99,183 shares worth $504K. The position accounts for 0.01% of the portfolio, ranked #554.

J. Goldman & Co first reported a position in PYPD in Q4 2024 and has held it in 7 quarters since. The position peaked at $748K in Q4 2025. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

  • J. Goldman & Co held 99,183 shares of PolyPid worth $504K as of Q2 2026.
  • J. Goldman & Co sold 50,316 PolyPid shares in Q2 2026, an estimated $232K.
  • PolyPid made up 0.01% of J. Goldman & Co's portfolio in Q2 2026, its #554 holding.
  • J. Goldman & Co first reported a position in PolyPid in Q4 2024 and has held it in 7 quarters since.
  • J. Goldman & Co's PolyPid position peaked at $748K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.